ESC 365 - Targeting PCSK9 for hypercholesterolemia.

Open Access

Targeting PCSK9 for hypercholesterolemia.

Session: New approaches in lipid-lowering therapy: from molecular medicine to therapeutic opportunities

Topic: Miscellaneous

Speaker: Professor A. Catapano (Milan, IT)

Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

About the speaker

Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)

46 presentations

3 followers

3 more presentations in this session

Molecular drivers of atherosclerotic plaque formation

Speaker: Professor M. Simons (New Haven, US)

Sequence variants affecting blood lipids: an update

Speaker: Doctor H. Holm (Reykjavik, IS)

Lipid abnormalities and heart disease: current challenges and research perspectives.

Speaker: Professor P. Perrone-Filardi (Naples, IT)

Access the full session

New approaches in lipid-lowering therapy: from molecular medicine to therapeutic opportunities

Speakers: Professor A. Catapano, Professor M. Simons, Doctor H. Holm, Professor P. Perrone-Filardi

About the event

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress

ESC 365 is supported by